The IBTS is developing a new service to allow the determination of blood groups by typing patient’s and donor’s DNA.
We started Weak D Genotyping in April 2017, and RHD/RHCE genotyping on selected patients in April 2017.
We are committed to developing a high quality service providing the most appropriate molecular blood group investigations for patients.
We plan to introduce further tests by the end of 2017, or early 2018.
A key investigation we will offer will be a Fetal RHD Screen. This test will determine fetal RHD type by testing cell-free DNA extracted from maternal plasma.
This test is nearing completion of validation.
Blood Group Genetics
Irish Blood Transfusion Service
National Blood Centre